Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Azim, H A; Michiels, S; Zagouri, F; Delaloge, S; Filipits, M; Namer, M; Neven, P; Symmans, W F; Thompson, A; André, F; Loi, S; Swanton, C

Azim, H A; Michiels, S; Zagouri, F; Delaloge, S; Filipits, M; Namer, M; Neven, P; Symmans, W F; Thompson, A; André, F; Loi, S; Swanton, C.

Affiliation

Azim HA; Breast Cancer Translational Research Laboratory BCTL, J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Ann Oncol ; 24(3): 647-54, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23337633

Subject(s)

Breast Neoplasms/diagnosis; Breast Neoplasms/genetics; Evaluation Studies as Topic; Female; Humans; Molecular Diagnostic Techniques/standards; Multivariate Analysis; Oligonucleotide Array Sequence Analysis; Practice Guidelines as Topic; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Evaluation_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: Belgium

Fulltext

XML

PubMed Links

Search on Google